Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.118.083907
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2018
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)